4th International Regional (North America) Stress and Behavior Conference
June 22-24, 2014 New Orleans, Louisiana
An annual international event gathering scientists and psychiatrists from around the world to share an interest in stress-evoked brain disorders in both humans and animals.
Conference Secretariat
Tel: + 1 (240) 899-9571
info@stressandbehavior.com
Biomarkers for a Successful Pregnancy
Thursday, 17 October 2013 09:00 - 17:00 London, United Kingdom
Successful biomarker profiling in pregnant or prenatal women could not only help predict the pregnancy risk to mothers, but also survival rate of the unborn child and any possible future complications. There is a wide range of possibility for using biomarkers in pregnancy and prenatal testing. For example, research is currently being undertaken to identify biomarkers for
Identifying
· ectopic pregnancy
· potential rejection of pregnancy by the mother
· possible cardiovascular issues
· maternal autoimmune development
· hypertensive disorders
Assessing
· pregnancy outcome
Revealing
· Maternal Alcohol Consumption
· Maternal tobacco use
Avoiding
· reducing multiple pregnancy
to highlight just a few. This event aims to focus on the current research in this area and discuss the way forward in using biomarkers as a predictive and diagnostic tool to improve pregnancy outcome internationally
This event has CPD accreditation and is part of the 2013 Pregnancy Summit - www.PregnancySummit2013.com
Who Should Attend
Biotech and Pharma Industry Managers: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research working in the field of biomarkers or pregnancy
Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students working in the field of biomarkers or pregnancy
Clinicians: Anyone working in the field of pregnancy and diagnosing pregnancy-related illnesses and pregnancy outcome
Contact Details
Email: enquiries@euroscicon.com
Web: www.lifescienceevents.com
Phone: 07507 799380
NGS 2013 Manchester: Applications & Bottlenecks
5th – 6th November 2013 Manchester, United Kingdom
The aim of our NGS conferences is to address key issues being faced by laboratories that are implementing Next Generation Sequencing (NGS) into their workflows. Whilst NGS is a very powerful technology that holds the promise of unlocking the secrets of DNA sequences on a large scale, its implementation has not been as smooth as anticipated.
Our previous co-organized event in this area – NGS2013 Oxford Workshop & Symposium – focussed on bioinformatics, but with the current NGS conference in Manchester we want to take the theme a step further by broadening the discussion areas
Whether your laboratory is working in the area of clinical genetics, animal, plant or microbial genetics you will be aware that there are common issues that unite researchers in all of these fields when it comes to establishing workflows for NGS. These issues which have become recognized bottlenecks across all areas of NGS based research include but are not limited to Library generation, Data analysis and Data storage. Whilst these issues are now being addressed by start-up as well as established biotech companies, they are being tackled in isolation of the entire NGS workflow.
The NGS 2013 Manchester conference will bring together leading experts from widely diverse backgrounds to tackle these issues by networking, discussing the common bottlenecks and working with biotech companies to try and mitigate these issues. We strive to keep our conferences informal and create a good personal atmosphere so as to facilitate dialogue and networking amongst all participants.
The result is an NGS conference that gather researchers from Pharma, Biotech, Hospitals and Universities who are working in areas and applications that benefit each other when discussed in the context of common NGS bottlenecks. Researchers working in the areas of micro RNA’s, Exome & Genomic sequencing, NGS panels, inherited diseases, expression analysis, viral genomics to name but a few areas can now listen to each other and find effective strategies and partners that will help in ironing out the bottlenecks.
Who should attend:
1. All NGS users, researchers and students
2. Bioinformaticians
3. NHS Labs and private companies, Pharma, Biotech and Agro Companies
Geneticists interested in the latest developments of:
• Bioinformatics
• Biomarkers
• Computational Biology
• Data Analysis
• Data interpretation
• DNA Sequencing
• Genetics/Genomics
• Infectious and inherited Diseases
• Informatics
• Molecular and Cell Biology
• Molecular Diagnostics
• Next Generation Sequencing
Global Health 2013, The Second International Conference on Global Health Challenges
November 17 - 22, 2013 - Lisbon, Portugal
Colocated with other events part of DataSys 2013
Tracks:
FUNDAMENTALS
Foundations in global health informatics; Computational health; Software for health; Independent living technologies; ICT and health; Platform interoperability; Semantic interoperability; Diagnosis systems; Applied health informatics; User interfaces and visualization
TECHNOLOGY
Bio-medical semantics; Bio-medicine; Disease biomarker prediction; Applications of bio-nano technology; Body networks; Mobile healthcare; Ubiquitous healthcare
TRENDS
Clinical epigenetic; Long term health conditions; Ambient assisted; Genetics; Virtual reality in medicine surgery; Clinical trials; Computational and knowledge management on proteomics and genomics; Drug design, disease diagnosis and control
PRACTICE
Nursing; Patient-centered care; Personalized medicine; Pervasive health; Homecare; Pharmaceutical services
ALTERNATIVE
Biomedicine; Natural medicine; Preventive medicine; Chronic diseases following; Home surveillance
CHALLENGES
Security aspects and access control on medical data; Data management in pervasive context; Data quality assurance and provenance; Patient flow models in hospitals; Clinical data analysis; Information visualization of medical data
GLOBAL
eHealth initiatives; Social medicine; Health global accessibility; Epidemic spreading and control; Health Education; Providing health in remote areas; Decision support within healthcare; Ethical aspects in eHealth; Healthcare plans and patient benefits; Synchronization of federal regulations; Availability of medication; Community health services
Cancer in Africa: Bridging Science and Humanity
21-24 November 2013 Durban, South Africa
The African Organisation for Research and Training in Cancer is pleased to announce its 9th International Conference on Cancer in Africa. It will take place in Durban, South Africa from 21-24 November 2013 at the International Convention Centre Durban.
Held every two years, the AORTIC conferences provide a unique platform to bring together leading African and international health care professionals in cancer care, advocates, leaders in Government, and various members of the international health industry and global cancer community to meet and discuss cancer-related matters and proffer solutions to significantly reduce the impact of cancer in Africa and indeed around the world. To make a difference, AORTIC invites you, as a committed member of the international cancer control community, to contribute to and listen to world-renowned speakers, to network with colleagues and professionals from all over the world, and to be exposed to the latest research findings in the cancer arena.
The target audience for AORTIC’s 9th International Cancer Conference is anyone interested in the cancer burden in Africa, including physicians, nurses, social workers, researchers, and representatives of NGOs and international businesses.
The programme will address cutting edge cancer management and basic science and clinical research on cancers relevant to Africa. This will include the following topics: National Cancer Control Plans (NCCPs), Cancer Registration, Basic Sciences, Genetics, Epigenetics, Site-specific Cancers, Biomarkers, Radiation, Chemotherapy, Epidemiology, HIV-AIDS-related Cancers, Haematology, Cancer Advocacy, Tobacco-related Cancers, Paediatric Oncology, Palliative Care, and Oncology Nursing.
International Conference on Intelligent Biology and Medicine (ICIBM 2013)
August 11-13, 2013, Nashville, Tennessee
Bioinformatics, Systems Biology and Intelligent Computing are synergistic disciplines that hold great promise for the advancement of biomedical research and development through the design of intelligent systems to solve engineering practical problems as well as translational science problems. Research and development in these areas impact science and technology, and synergies among these disciplines provide enormous potential. The International Conference on Intelligent Biology and Medicine (ICIBM) aims to provide a forum for the cross-fertilization of ideas and promotion of interdisciplinary collaborations. Keeping these objectives in mind, ICIBM solicits original contributions in the following non-exclusive lists of areas.
Bioinformatics
Functional genomics, personalized medicine, genetics and genomics, multi-dimensional data integration, next generation sequencing analysis (including algorithms, tools and data analysis), microarray based data analysis, biomedical data analysis, bio-molecular and phylogenetic databases, bio-languages, interoperability in bio-databases, bio-ontology and data mining, identification and classification of genes, sequence search and alignment, protein structure prediction and molecular simulation, molecular evolution and phylogeny, proteomics, drug discovery, drug design, bioinformatics engineering, bio-data visualization, algorithms, modeling and simulation of bio-datasets, biomarker discovery, bio-imaging, signaling and computation.
Systems Biology
Modeling and simulation of biological processes, pathways, networks, regulatory networks, pipelines, mathematical and quantitative models of cellular and multi-cellular systems, emergence of properties in complex biological systems, methods to predict biological network behavior from incomplete information, statistical modeling of biological data, prediction and validation, synthetic biological systems, high performance bio-computing, self-organization in living systems (cells, organisms, swarms, ecosystems, etc.), platforms for computational modeling of living systems (parallel, distributed, and multi-resolution simulation methods), differential, discrete and/or stochastic modeling-language frameworks, applications of systems biology towards understanding disease mechanisms, pharmaceutical drug discovery and drug target validation.
Intelligent Computing
Machine learning, data mining, knowledge discovery, pattern recognition, natural langue processing, literature mining, semantic and ontology driven biological data analysis, neural computing, kernel methods, evolutionary computing, swarm intelligence and optimization, feature selection/extraction, ensemble methods, manifold learning theory, artificial life and artificial immune systems, technology to develop artificial components, systematization methodology for intelligent systems, and scientific principles related to artificial life.
For general questions/inquiries, please email us at icibm.list@gmail.com.
European Association of Centres of Medical Ethics Annual Conference
September 19-21, 2013 Bochum, Germany
“Personalised medicine” – medicine for the person? Ethical challenges for medical research and practice
The Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Germany, and the European Association of Centres of Medical Ethics (EACME) will organise the EACME annual conference in 2013. The conference will be organised in cooperation with the Centre for Medical Ethics Bochum (ZME e.V.) and supported by the Research Ethics Committee of the Medical Faculty, Ruhr University Bochum.
Contact details and further information:
President of the Conference: Prof. Dr. med. Dr. phil. Jochen Vollmann
Scientific Secretary: PD Dr. med. Jan Schildmann, M.A.
Institute for Medical Ethics and History of Medicine
Ruhr University Bochum
Markstrasse 258a
44799 Bochum
Germany
Tel.: 0049 234-32-23394
Fax: 0049 234-32-14205
E-mail: info(at)eacme2013.org
Conference website: www.eacme2013.org
Up Close and Personalized, International Congress on Personalized Medicine
July 25-28, 2013 Paris, France
Personalized Medicine is revolutionizing the medical world. Understanding and integrating genetic and molecular information with traditional clinical knowledge is the hallmark of this transformation. At present much of the medical practice is based on standards of care derived from the epidemiologic studies of large cohorts that do not take into account the individual’s genetic, proteomic, and metabolic characteristics. Furthermore, in spite of efforts to develop data-driven, expert–based, clinical decision support systems, there are no clear and simple means to disseminate new findings into clinical practice.
Following the great success of the meeting in Florence Italy last year, the main focus of the second Up Close and Personalized Congress is to examine the essential clinical, imaging, genomic, proteomic, metabolomic, pharmacogenomic and biomarker data necessary to predict, prevent and treat major medical conditions concerning metabolism (diabetes and obesity) and cancer. As in the first meeting one of the key themes will be to explore bio-informatic tools, algorithms, decision support systems and other new platforms for disease prediction and better tailoring treatment modeling to the individual patient. Furthermore, we will discuss health policy issues such as barriers for implementing Personalized Medicine, and quality assurance.
Topics
Diabetes
Diagnostics
Health Policy
Imaging
Informatics
Obesity
Oncology
Contact Us
Please do not hesitate to contact us with any questions or queries on Up Close and Personalized – The 2nd International Congress on Personalized Medicine.
Congress Secretariat
Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0) 22 5330 948
Fax: +41 (0) 22 5802 953
Email: Secretariat@upcp.org
34th Annual Conference of the International Society for Clinical Biostatistics
25-29 August 2013 Munich, Germany
This conference will serve as an important scientific forum for the exchange of new ideas and applications among biostatisticians, epidemiologists, medical researchers, and clinical pharmacologists from all over the world of healthcare and medicine.An array of fascinating topics has been organized by the conference´s Scientific Programme Committee, including biomarker-based clinical trial designs, statistics for global clinical trials, and social networks in infectious diseases.
This year´s customary Thursday Symposium will address topics related to individual prediction, personalized medicine, vaccination, and guidelines for prognostic research, which are sure to provide stimulating discussions and fuel for thoughts.
2nd World Congress on Thyroid Cancer
July 10-14, 2013 Toronto, Canada
The 2nd WCTC is a global multi-disciplinary meeting of all specialists involved in the field of Thyroid Cancer. Join us at this cutting-edge, state-of-the-art, multidisciplinary Congress covering the entire spectrum of thyroid nodules and thyroid cancer. The Congress program focuses on the most recent advances in this field and will appeal to a broad audience of specialists. The scientific program includes keynotes, lectures, panels, workshops, instructional courses, meet the professors, video sessions, auxiliary symposiums, scientific and commercial exhibits. A full social program each evening provides the opportunity to network with colleagues and international experts.
